Fundz

Biofourmis Raises Additional Funding From Intel Capital In Series D Extension And Names Top Healthcare Leaders To Its Board

PRIVATEAug 10, 2022

Round Type

Series D

NashvilleBiotechnologySoftwareData And AnalyticsHealth CareArtificial IntelligenceLife Science

Description

Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M. The initial Series D funding round was announced in April and was led by global growth equity firm General Atlantic with participation by CVS Health (NYSE:CVS), Trevor Fetter and existing investors.

Who else raised in Data And Analytics and Life Science around the same time

Companies in the same sectors as Biofourmis that raised within 45 days of this round, from Fundz verified event records.

  • Sympatic raised an undisclosed amount (Pre-Seed) on August 4, 2022.
  • Leuko raised $5M (Series A) on September 23, 2022.
  • Surgimate raised an undisclosed amount (Corporate Round) on September 20, 2022.
  • PassiveLogic raised $15M (Funding Round) on September 20, 2022.
  • Incepto raised $27M (Funding Round) on September 19, 2022.
  • GBB raised $15M (Series B) on September 14, 2022.

Who to call at Biofourmis, and when

A new round usually means Biofourmis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biofourmis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biofourmis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biofourmis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biofourmis

Location

Nashville, Tennessee, United States

About

Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biofourmis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Biofourmis's next move

See what Strategic adds

Biofourmis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.